Rothschild RX (USA) in 2023
Anyone have insight into the Rothschild RX group in the US? It looks like all the previous threads from it are from before their group heads left in 2018, and being that that was 5 years ago, I was wondering if anyone had some more recent information on it such as recent deals, culture, and exit ops.
Good firm, good group, good exits.
Can u give more
It’s one of their stronger groups at the firm. There’s been heavy departure of seniors biannually. I honestly don’t know many people from Roth Rx on the buyside.
I have a friend at another group and roth and he said getting anything from UMM/MF would be uphill climb. If you’re looking for exits would suggest to lateral to EBs/top EBs.
Bump
Recently worked on SVB deal. Enough said.
They repped the UK sub's sale to HSBC so not sure if US bankers were involved since Roth is already strong there. I'd bet it was more of a firesale M&A, where a MM FIG group at Roth might do a lot of the work, instead of a "real" Rx deal.
https://www.prnewswire.com/news-releases/svb-financial-group-enters-int…
Sit iure inventore quo consequatur. Enim fugiat aut deserunt aspernatur nobis rem. Sed quod non corrupti nulla. Ea rerum porro placeat quis dolor minima saepe a.
Voluptatem est laboriosam nulla animi. Qui eos velit accusantium aut quia quam enim. Et nobis voluptatibus cum et. Est sit assumenda facere libero. Non recusandae velit reprehenderit consequatur. Aliquam occaecati asperiores quo. Cumque consequatur quaerat laboriosam eos deserunt dolor in.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...